Skip to main content

Cardiff Lexington Corp

corporate_fare Company Profile

Cardiff Lexington Corp

CDIX·OTC·Industrial Applications And Services·CIK 0000811222

Our company is a targeted healthcare holding company that acquires and builds middle-market niche healthcare clinics, primarily in orthopedics, spine care, and pain management. Our acquisition strategy focuses on three complementary pillars: Core Cash Flow, which involves acquiring, optimizing, and managing physician practices; Asset Acquisition, which expands our footprint through ownership of real estate assets like ambulatory surgery centers and orthopedic clinics; and Finance, which retains and manages personal injury practice accounts receivable. We focus on acquiring orthopedic and related modality practices with strong organic growth plans that are materially cash generative. All current revenue is derived from Nova Ortho and Spine, LLC, or Nova, which was acquired on May 31, 2021. Nova operates a group of regional primary specialty and ancillary care facilities across Florida and Georgia. These facilities provide traumatic injury victims with primary care evaluations, interventional pain management, and specialty consultation services, including emergency medical condition, or EMC, assessments. We primarily focus on plaintiff-related care and provide healthcare to uninsured patients who have typically been in an accident and filed a lawsuit. We offer a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. We also own a real estate company, Edge View Properties, Inc., or Edge View, which was acquired on July 16, 2014.

Cardiff Lexington Corp (OTC:CDIX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors CDIX SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Cardiff Lexington Registers Up to $75M Highly Dilutive Equity Offering
  • Cardiff Lexington Secures Up to $75M Equity Facility, Posing Significant Dilution Risk
  • Cardiff Lexington Secures Highly Dilutive $25M-$75M Equity Purchase Facility
  • Cardiff Lexington Reports Widened Net Loss, Secures Highly Dilutive Debt, and Faces Lawsuit from Former Chairman
  • Cardiff Lexington Corp Faces Going Concern Doubt Amidst Widening Losses and Dilutive Financing

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$11.54M
Net Income
-$5.51M
Gross Profit
$7.21M
Operating Income
$1.1M
Cash & Equivalents
$318.54K
Debt / Equity
0.00×
Net Margin
-47.7%
Shares Outstanding
13.7M sh
Source: 10-K · filed 2026-03-10 · accession 0001683168-26-001639
Browse all tickers starting with C →
$1.4
52-week range · as of 2026-06-11 $0.934 – $315
Market cap
$21.4M
Volume
300 (0.1× avg)
3-mo avg 2.1K
Live data · 2026-06-14 03:50 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CDIX - Latest Insights

CDIX
Jun 11, 2026, 4:36 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $1.72
Real-time Price: $1.40 info
Change: -$0.3176 (-18%) info
Market Cap: $21.396M info
CDIX
Jun 11, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.72
Real-time Price: $1.40 info
Change: -$0.3176 (-18%) info
Market Cap: $21.396M info
CDIX
Jun 11, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.72
Real-time Price: $1.40 info
Change: -$0.3176 (-18%) info
Market Cap: $21.396M info
CDIX
May 13, 2026, 1:37 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.24
Real-time Price: $1.40 info
Change: -$0.840 (-38%) info
Market Cap: $21.396M info
CDIX
Mar 10, 2026, 3:06 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $3.10
Real-time Price: $1.40 info
Change: -$1.70 (-55%) info
Market Cap: $21.396M info
CDIX
Feb 05, 2026, 3:19 PM EST
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $1.30
Real-time Price: $1.40 info
Change: +$0.100 (+8%) info
Market Cap: $21.396M info
CDIX
Feb 03, 2026, 3:59 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.30
Real-time Price: $1.40 info
Change: +$0.100 (+8%) info
Market Cap: $21.396M info
CDIX
Jan 20, 2026, 4:59 PM EST
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $1.30
Real-time Price: $1.40 info
Change: +$0.100 (+8%) info
Market Cap: $21.396M info
CDIX
Jan 05, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $1.40 info
Change: -$0.250 (-15%) info
Market Cap: $21.396M info